We have located links that may give you full text access.
Oxidative Lipoprotein Markers Predict Poor Functional Outcome in Patients with Minor Stroke or Transient Ischemic Attack.
European Journal of Neurology 2019 Februrary 22
BACKGROUND AND PURPOSE: Oxidative stress plays an important role in acute ischemic stroke. However, the association of oxidative lipoprotein markers, including oxidized low-density lipoprotein (oxLDL), oxLDL/ high density lipoprotein (HDL), and oxLDL/ low density lipoprotein (LDL), with functional outcome of minor stroke or transient ischemic attack (TIA) remains unclear. We aimed to investigate the association between oxidative lipoprotein markers and poor functional outcome in patients with minor stroke or TIA.
METHODS: All patients with minor stroke or TIA were recruited from the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events (CHANCE) trial. The poor functional outcome included modified Rankin Scale (mRS) 2-6 and 3-6 at 90-day and 12-month follow-up. Multivariate logistic regression were used to investigate the associations of oxLDL, oxLDL/HDL, and oxLDL/LDL with poor functional outcome.
RESULTS: Among 3019 patients included in this study, the median (interquartile range) of oxLDL, oxLDL/HDL, and oxLDL/LDL were 13.96 (6.65-28.81) ug/dL, 4.52 (2.08-9.32), and 11.73 (5.27-24.85), respectively. After adjusted for confounding factors, patients in the highest oxLDL quartile had a higher proportion of mRS 2-6 at 90 days (HR, 1.78; 95% CI, 1.26-2.52) and 12 months (HR, 1.42; 95% CI, 1.01-1.99), mRS 3-6 at 90 days (HR, 1.98; 95% CI, 1.29-3.04) and 12 months (HR, 1.77; 95% CI, 1.09-2.89), when compared to the lowest oxLDL quartile (P< 0.05). Similar results were found for oxLDL/HDL and oxLDL/LDL.
CONCLUSIONS: Higher levels of oxidative lipoprotein markers are independent predictors of poor functional outcome in patients with minor stroke or TIA at 90 days and 12 months. This article is protected by copyright. All rights reserved.
METHODS: All patients with minor stroke or TIA were recruited from the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events (CHANCE) trial. The poor functional outcome included modified Rankin Scale (mRS) 2-6 and 3-6 at 90-day and 12-month follow-up. Multivariate logistic regression were used to investigate the associations of oxLDL, oxLDL/HDL, and oxLDL/LDL with poor functional outcome.
RESULTS: Among 3019 patients included in this study, the median (interquartile range) of oxLDL, oxLDL/HDL, and oxLDL/LDL were 13.96 (6.65-28.81) ug/dL, 4.52 (2.08-9.32), and 11.73 (5.27-24.85), respectively. After adjusted for confounding factors, patients in the highest oxLDL quartile had a higher proportion of mRS 2-6 at 90 days (HR, 1.78; 95% CI, 1.26-2.52) and 12 months (HR, 1.42; 95% CI, 1.01-1.99), mRS 3-6 at 90 days (HR, 1.98; 95% CI, 1.29-3.04) and 12 months (HR, 1.77; 95% CI, 1.09-2.89), when compared to the lowest oxLDL quartile (P< 0.05). Similar results were found for oxLDL/HDL and oxLDL/LDL.
CONCLUSIONS: Higher levels of oxidative lipoprotein markers are independent predictors of poor functional outcome in patients with minor stroke or TIA at 90 days and 12 months. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app